Plain-English translation of NCT05786742 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a shorter, more intense radiation therapy schedule works as well as a longer, gentler schedule for treating localized prostate cancer. Both approaches combine external beam radiation therapy with a high-dose internal radiation implant (called brachytherapy). The goal is to find the best balance between destroying cancer cells and minimizing side effects.
Standard prostate cancer radiation treatment usually takes several weeks. Doctors want to know if completing treatment in just one week (ultra-short schedule) is safe and effective, which could make treatment more convenient for patients while maintaining or improving outcomes.
You likely qualify if…
You likely don't qualify if…
You would first undergo a brachytherapy procedure under anesthesia, where thin catheters are placed directly into the prostate to deliver a high radiation dose. One week later, you would begin external radiation therapy over 5 days (spread across roughly one week). You would receive imaging scans and planning sessions before treatment starts. The entire active treatment phase lasts about two weeks, after which you would have follow-up visits to monitor your recovery and treatment response.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Canada